Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Among authors: mcdonald v. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.
Kuter DJ, Mayer J, Efraim M, Bogdanov LH, Baker R, Kaplan Z, Garg M, Trněný M, Choi PY, Jansen AJG, McDonald V, Bird R, Gumulec J, Kostal M, Gernsheimer T, Ghanima W, Daak A, Cooper N. Kuter DJ, et al. Among authors: mcdonald v. Blood Adv. 2024 Apr 9;8(7):1715-1724. doi: 10.1182/bloodadvances.2023012044. Blood Adv. 2024. PMID: 38386978 Free PMC article. Clinical Trial.
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Takhar P, Geirnaert M, Gavura S, Beca J, Mercer RE, Denburg A, Muñoz C, Tadrous M, Parmar A, Dionne F, Boehm D, Chambers C, Craig E, Trudeau M, Cheung MC, Houlihan J, McDonald V, Pechlivanoglou P, Taylor M, Wasylenko E, Wranik WD, Chan KKW. Takhar P, et al. Among authors: mcdonald v. Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141. Curr Oncol. 2024. PMID: 38668044 Free PMC article.
Realignment of clinical research after the COVID-19 era.
Thomas D, McDonald VM, Gibson PG. Thomas D, et al. Among authors: mcdonald vm. Lancet Respir Med. 2024 Apr 10:S2213-2600(24)00080-8. doi: 10.1016/S2213-2600(24)00080-8. Online ahead of print. Lancet Respir Med. 2024. PMID: 38614105 No abstract available.
Landscape fire smoke airway exposure impairs respiratory and cardiac function and worsens experimental asthma.
Gomez HM, Haw TJ, Ilic D, Robinson P, Donovan C, Croft AJ, Vanka KS, Small E, Carroll OR, Kim RY, Mayall JR, Beyene T, Palanisami T, Ngo DTM, Zosky GR, Holliday EG, Jensen ME, McDonald VM, Murphy VE, Gibson PG, Horvat JC. Gomez HM, et al. Among authors: mcdonald vm. J Allergy Clin Immunol. 2024 Mar 19:S0091-6749(24)00272-0. doi: 10.1016/j.jaci.2024.02.022. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 38513838 Free article.
Perceptions of and preferences for PrEP use among African American women and providers in the U.S. South: a qualitative study.
Waldron EM, Goodman GR, Rivas AM, Ott C, Blyler A, McDonald VW, Campbell M, Underwood E, Bonner A, Wise JM, Elopre L, Kudroff K, Krakower D, Sherr K, Kempf MC, Psaros C. Waldron EM, et al. Among authors: mcdonald vw. Psychol Health. 2024 Mar 5:1-20. doi: 10.1080/08870446.2024.2322079. Online ahead of print. Psychol Health. 2024. PMID: 38441003
404 results